Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
132.00
Dollar change
-0.54
Percentage change
-0.41
%
Index- P/E54.32 EPS (ttm)2.43 Insider Own2.60% Shs Outstand98.70M Perf Week-1.98%
Market Cap13.14B Forward P/E18.92 EPS next Y6.98 Insider Trans-22.95% Shs Float96.92M Perf Month-6.15%
Income249.70M PEG3.02 EPS next Q1.10 Inst Own92.64% Short Float2.50% Perf Quarter-3.91%
Sales1.89B P/S6.96 EPS this Y106.86% Inst Trans-1.46% Short Ratio2.79 Perf Half Y17.63%
Book/sh22.61 P/B5.84 EPS next Y36.55% ROA8.71% Short Interest2.43M Perf Year25.87%
Cash/sh10.37 P/C12.73 EPS next 5Y18.00% ROE12.68% 52W Range89.04 - 148.37 Perf YTD0.18%
Dividend Est.- P/FCF36.33 EPS past 5Y62.04% ROI10.03% 52W High-11.03% Beta0.29
Dividend TTM- Quick Ratio2.40 Sales past 5Y34.77% Gross Margin96.95% 52W Low48.25% ATR (14)3.80
Dividend Ex-DateDec 29, 1995 Current Ratio2.45 EPS Y/Y TTM57.90% Oper. Margin20.92% RSI (14)37.91 Volatility2.89% 3.08%
Employees1400 Debt/Eq0.21 Sales Y/Y TTM26.76% Profit Margin13.23% Recom1.75 Target Price152.90
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q63.53% Payout0.00% Rel Volume0.64 Prev Close132.54
Sales Surprise-0.64% EPS Surprise18.81% Sales Q/Q25.05% EarningsMay 01 BMO Avg Volume868.84K Price132.00
SMA20-4.11% SMA50-3.06% SMA2009.85% Trades Volume556,053 Change-0.41%
Date Action Analyst Rating Change Price Target Change
Dec-13-23Resumed Citigroup Neutral $127
Dec-12-23Initiated Deutsche Bank Buy $136
Oct-24-23Resumed Cantor Fitzgerald Overweight $135 → $140
Aug-21-23Reiterated Mizuho Neutral $112 → $113
Jul-24-23Upgrade SVB Securities Market Perform → Outperform $115 → $125
Jul-06-23Upgrade BMO Capital Markets Underperform → Market Perform $91 → $96
May-04-23Upgrade Guggenheim Neutral → Buy $145
Mar-30-23Upgrade Canaccord Genuity Hold → Buy $124 → $132
Mar-03-23Upgrade Evercore ISI In-line → Outperform $130
Feb-03-23Upgrade Morgan Stanley Equal-Weight → Overweight $120 → $130
Apr-16-24 04:01PM
02:30AM
Apr-10-24 04:01PM
Apr-09-24 07:37AM
Apr-03-24 08:30AM
08:30AM Loading…
Mar-28-24 08:30AM
Mar-24-24 09:19AM
Mar-23-24 08:00AM
Mar-16-24 08:00AM
01:23AM
01:23AM
Mar-15-24 10:00AM
Mar-13-24 01:26AM
Mar-11-24 04:01PM
01:12PM
04:45PM Loading…
Mar-06-24 04:45PM
Mar-01-24 12:40AM
Feb-27-24 04:01PM
Feb-22-24 11:28PM
03:55AM
Feb-15-24 11:36PM
Feb-10-24 10:18AM
12:14AM
Feb-09-24 02:23AM
Feb-08-24 09:13AM
12:20AM
Feb-07-24 09:30AM
07:33AM
07:18AM
07:00AM
09:16AM Loading…
Feb-05-24 09:16AM
Feb-02-24 11:02PM
Jan-31-24 10:00AM
Jan-24-24 11:02PM
06:54AM
Jan-22-24 09:38AM
Jan-17-24 04:16PM
Jan-12-24 09:35AM
Jan-11-24 09:02PM
Jan-10-24 09:24AM
Jan-05-24 02:02AM
Jan-02-24 04:01PM
Dec-26-23 06:56PM
07:22AM
Dec-25-23 08:23PM
Dec-20-23 04:54AM
Dec-16-23 01:01PM
Dec-15-23 02:30PM
Dec-12-23 03:05PM
Dec-10-23 11:15AM
Dec-09-23 11:05AM
Dec-06-23 03:01AM
Dec-05-23 04:01PM
Dec-02-23 05:06AM
Dec-01-23 07:00AM
Nov-30-23 05:04AM
Nov-13-23 06:07PM
07:00AM
Nov-09-23 04:01PM
Nov-08-23 04:05PM
04:01PM
Nov-06-23 09:45AM
Nov-02-23 08:30AM
Nov-01-23 06:34PM
Oct-31-23 09:30AM
08:32AM
08:15AM
07:05AM
07:00AM
Oct-24-23 10:00AM
Oct-20-23 11:43AM
Oct-18-23 11:13AM
Oct-16-23 12:53PM
Oct-10-23 04:01PM
Oct-05-23 11:41AM
07:00AM
03:01AM
Oct-03-23 12:45PM
Sep-26-23 04:32PM
Sep-21-23 09:15AM
Sep-14-23 07:04PM
08:30AM
Sep-12-23 04:05PM
12:18PM
07:30AM
Sep-11-23 07:01PM
08:30AM
Sep-06-23 08:00AM
Aug-31-23 04:01PM
Aug-29-23 08:30AM
Aug-28-23 08:30AM
Aug-27-23 08:53AM
Aug-18-23 04:34PM
Aug-13-23 05:49PM
Aug-02-23 03:53PM
Aug-01-23 09:30AM
08:25AM
07:25AM
07:00AM
Jul-26-23 10:02AM
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BENEVICH ERICChief Commercial OfficerApr 15 '24Option Exercise81.2119,8181,609,43153,365Apr 17 05:19 PM
BENEVICH ERICChief Commercial OfficerApr 15 '24Sale133.3619,8182,643,02040,778Apr 17 05:19 PM
Delaet IngridChief Regulatory OfficerApr 01 '24Option Exercise79.0227221,4937,779Apr 03 04:44 PM
Delaet IngridChief Regulatory OfficerApr 01 '24Sale137.3027237,3467,507Apr 03 04:44 PM
Delaet IngridChief Regulatory OfficerMar 21 '24Option Exercise103.525,000517,60012,507Mar 25 06:02 PM
Delaet IngridChief Regulatory OfficerMar 21 '24Sale145.065,000725,3207,507Mar 25 06:02 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Option Exercise80.9075,0006,067,628110,299Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Option Exercise39.7940,0001,591,60020,000Mar 15 05:25 PM
BENEVICH ERICChief Commercial OfficerMar 14 '24Sale139.3875,00010,453,41740,778Mar 15 05:33 PM
MORROW GEORGE JDirectorMar 14 '24Sale139.4240,0005,576,7100Mar 15 05:25 PM
POPS RICHARD FDirectorMar 13 '24Option Exercise42.7623,200992,03252,712Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Option Exercise106.023,000318,06010,507Mar 15 05:15 PM
POPS RICHARD FDirectorMar 13 '24Sale140.3323,2003,255,62129,512Mar 15 05:19 PM
Delaet IngridChief Regulatory OfficerMar 13 '24Sale140.143,000420,4197,507Mar 15 05:15 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Option Exercise106.0220021,2047,707Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Option Exercise42.761004,27629,612Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 11 '24Sale140.0020028,0007,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 11 '24Sale140.0010014,00029,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Option Exercise106.021,800190,8369,307Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Option Exercise42.761,70072,69231,212Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerMar 08 '24Sale140.031,800252,0537,507Mar 12 06:38 PM
POPS RICHARD FDirectorMar 08 '24Sale140.051,700238,07829,512Mar 12 06:47 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Option Exercise79.0227321,5727,780Feb 29 07:02 PM
Delaet IngridChief Regulatory OfficerFeb 29 '24Sale135.5127336,9947,507Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Option Exercise53.6775,0004,025,04393,759Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Option Exercise79.026,544517,10710,007Feb 29 07:02 PM
BENEVICH ERICChief Commercial OfficerFeb 28 '24Sale134.6975,00010,101,60840,616Feb 29 06:55 PM
Delaet IngridChief Regulatory OfficerFeb 28 '24Sale135.346,544885,6387,507Feb 29 07:02 PM
Norwalk Leslie VDirectorFeb 27 '24Option Exercise84.958,000679,6008,000Feb 29 06:50 PM
Norwalk Leslie VDirectorFeb 27 '24Sale135.678,0001,085,3880Feb 29 06:50 PM
POPS RICHARD FDirectorFeb 20 '24Option Exercise12.9815,000194,70044,512Feb 22 05:11 PM
POPS RICHARD FDirectorFeb 20 '24Sale132.4715,0001,987,04729,512Feb 22 05:11 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Option Exercise39.285,090199,951512,052Feb 14 05:17 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 13 '24Sale133.022,832376,700514,596Feb 15 05:43 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 13 '24Sale133.071,811240,9964,895Feb 15 05:33 PM
Onyia JudeChief Scientific OfficerFeb 13 '24Sale132.941,432190,37113,128Feb 15 05:48 PM
Gano KyleChief Business Development OffFeb 13 '24Sale132.891,352179,674135,166Feb 15 05:40 PM
ABERNETHY MATTChief Financial OfficerFeb 13 '24Sale132.851,352179,61231,528Feb 15 05:27 PM
ROBERTS EIRYChief Medical OfficerFeb 13 '24Sale132.961,114148,12223,716Feb 15 05:51 PM
BENEVICH ERICChief Commercial OfficerFeb 13 '24Sale133.011,098146,05040,616Feb 15 05:29 PM
Lippoldt DarinChief Legal OfficerFeb 13 '24Sale132.991,098146,02839,740Feb 15 05:45 PM
Cooke JulieChief Human Resources OfficerFeb 13 '24Sale133.04796105,90217,976Feb 15 05:35 PM
Delaet IngridChief Regulatory OfficerFeb 13 '24Sale133.0371695,2537,507Feb 15 05:38 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 08 '24Sale134.152,274305,052506,962Feb 08 07:21 PM
Cooke JulieChief Human Resources OfficerFeb 08 '24Sale135.441,329179,99517,263Feb 08 07:35 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 08 '24Sale135.411,328179,8304,895Feb 08 07:46 PM
ABERNETHY MATTChief Financial OfficerFeb 08 '24Sale134.21980131,52930,314Feb 08 07:12 PM
ROBERTS EIRYChief Medical OfficerFeb 08 '24Sale134.21980131,52222,717Feb 08 07:28 PM
Gano KyleChief Business Development OffFeb 08 '24Sale134.20980131,519133,952Feb 08 07:17 PM
BENEVICH ERICChief Commercial OfficerFeb 08 '24Sale134.19980131,50939,631Feb 08 07:15 PM
Lippoldt DarinChief Legal OfficerFeb 08 '24Sale134.24911122,28938,755Feb 08 07:25 PM
GORMAN KEVIN CHARLESChief Executive OfficerFeb 06 '24Sale142.183,040432,218504,919Feb 08 07:21 PM
Gano KyleChief Business Development OffFeb 06 '24Sale142.201,600227,522133,072Feb 08 07:17 PM
ABERNETHY MATTChief Financial OfficerFeb 06 '24Sale142.191,280182,00029,434Feb 08 07:12 PM
BENEVICH ERICChief Commercial OfficerFeb 06 '24Sale142.121,280181,91038,751Feb 08 07:15 PM
Cooke JulieChief Human Resources OfficerFeb 06 '24Sale142.071,215172,61717,263Feb 08 07:35 PM
ROBERTS EIRYChief Medical OfficerFeb 06 '24Sale142.241,121159,44621,837Feb 08 07:28 PM
Lippoldt DarinChief Legal OfficerFeb 06 '24Sale142.171,041147,99537,939Feb 08 07:25 PM
Boyer David W.Chief Corp. Affairs OfficerFeb 06 '24Sale141.9645664,7344,894Feb 08 07:46 PM
Delaet IngridChief Regulatory OfficerFeb 01 '24Sale139.7762387,0776,865Feb 02 07:14 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 31 '24Sale140.692,707380,845502,188Feb 02 07:21 PM
Boyer David W.Chief Corp. Affairs OfficerJan 31 '24Sale140.802,096295,1154,894Feb 02 07:07 PM
Cooke JulieChief Human Resources OfficerJan 31 '24Sale141.291,740245,84217,263Feb 02 07:11 PM
Gano KyleChief Business Development OffJan 31 '24Sale140.701,541216,813131,635Feb 02 07:17 PM
ROBERTS EIRYChief Medical OfficerJan 31 '24Sale140.791,457205,13220,832Feb 02 07:29 PM
ABERNETHY MATTChief Financial OfficerJan 31 '24Sale140.721,283180,53928,284Feb 02 07:00 PM
Lippoldt DarinChief Legal OfficerJan 31 '24Sale140.651,250175,81037,005Feb 02 07:24 PM
BENEVICH ERICChief Commercial OfficerJan 31 '24Sale140.781,207169,92737,601Feb 02 07:05 PM
Delaet IngridChief Regulatory OfficerJan 31 '24Sale141.9442259,8996,309Feb 02 07:14 PM
Onyia JudeChief Scientific OfficerJan 31 '24Sale141.9412617,88411,843Feb 02 07:26 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Option Exercise79.0210,000790,20045,882Jan 24 05:47 PM
Lippoldt DarinChief Legal OfficerJan 22 '24Sale139.8610,0001,398,55335,882Jan 24 05:47 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Option Exercise19.5962,0231,215,031561,777Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 09 '24Sale134.0162,0238,311,895499,754Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Option Exercise19.59105,8352,073,308605,589Jan 10 04:31 PM
GORMAN KEVIN CHARLESChief Executive OfficerJan 08 '24Sale132.44105,83514,016,523499,754Jan 10 04:31 PM
Gano KyleChief Business Development OffJan 02 '24Option Exercise19.5975,0001,469,250199,134Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Option Exercise12.9820,000259,60062,785Jan 04 06:26 PM
Gano KyleChief Business Development OffJan 02 '24Sale131.4775,0009,860,194130,250Jan 04 06:32 PM
RASTETTER WILLIAM HDirectorJan 02 '24Sale131.4711,0441,451,92751,741Jan 04 06:26 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Option Exercise73.0424,0001,752,90031,263Dec 27 04:08 PM
Cooke JulieChief Human Resources OfficerDec 22 '23Sale128.6624,0003,087,80817,263Dec 27 04:08 PM
LYONS GARY ADirectorDec 22 '23Sale130.0410,0001,300,443193,697Dec 27 04:10 PM
ROBERTS EIRYChief Medical OfficerDec 22 '23Sale126.7410,0001,267,44819,521Dec 27 04:15 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Option Exercise81.0513,9251,128,62136,499Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 12 '23Sale120.3013,9251,675,24029,521Dec 14 05:22 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Option Exercise81.0530024,31529,721Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 08 '23Sale120.1030036,03129,521Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Option Exercise78.5277,3796,076,12068,243Dec 11 06:18 PM
ROBERTS EIRYChief Medical OfficerDec 07 '23Sale120.3777,3799,314,31929,521Dec 11 06:18 PM
Lippoldt DarinChief Legal OfficerDec 06 '23Option Exercise43.2420,830900,68956,712Dec 08 06:23 PM
ROBERTS EIRYChief Medical OfficerDec 06 '23Option Exercise77.818,396653,29337,917Dec 08 07:09 PM
Lippoldt DarinChief Legal OfficerDec 06 '23Sale119.8620,8302,496,64835,882Dec 08 06:23 PM
ROBERTS EIRYChief Medical OfficerDec 06 '23Sale120.038,3961,007,78029,521Dec 08 07:09 PM
LYONS GARY ADirectorDec 01 '23Option Exercise12.985,00064,900208,697Dec 05 04:54 PM
LYONS GARY ADirectorDec 01 '23Sale116.775,000583,837203,697Dec 05 04:54 PM
Onyia JudeChief Scientific OfficerNov 29 '23Sale113.572,331264,73311,732Dec 01 05:41 PM
Lippoldt DarinChief Legal OfficerNov 27 '23Sale112.2710,9191,225,91135,882Nov 29 04:36 PM
Boyer David W.Chief Corp. Affairs OfficerOct 02 '23Sale112.681,437161,9214,894Oct 04 05:07 PM
LYONS GARY ADirectorSep 12 '23Option Exercise12.985,00064,900208,697Sep 14 04:51 PM